Helga Rübsamen-Schaeff

Helga Rübsamen-Schaeff is the founder of AiCuris GmbH & Co. KG, founded in 2006, where the title held was Managing Director from 2006 to 2015.
Dr. Rübsamen-Schaeff is the founder of Aicuris Anti-Infective Cures AG, founded in 2006, holding the title Member-Supervisory Board currently.
Current jobs include Chairman-Supervisory Board at Merck Healthcare KGaA, Member-Supervisory Board at 4SC AG since 2015, Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main since 1988, Member-Supervisory Board at Universitätsklinikum Bonn, Partner at E.
Merck KG, Member at Deutsche Akademie der Naturforscher Leopoldina eV, Member-Supervisory Board at Merck Life Science KGaA, and Member at Deutsche Akademie der Technikwissenschaften eV since 2022.
Former jobs include Scientific & Executive Director at Chemotherapeutic Research Institute Georg-Speyer-Haus from 1987 to 1993, Managing Director at Georg Speyer Haus from 1987 to 1993, SVP & Global Head-Anti Infective Research at Bayer HealthCare AG from 2001 to 2006, Senior VP & Head-Antiinfectives Research at Bayer AG from 2001 to 2006, and Member-Supervisory Board at Merck KGaA. Education includes a doctorate conferred in 1973 and an undergraduate degree conferred in 1971, both from the University of Münster.